Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger D Weiss

Showing results (201-210 of 271) with videos related to

Pageof 28
Sort By:
The American Journal on Addictions|August 18, 2021
Patients' perceptions of telehealth services for outpatient treatment of substance use disorders during the COVID-19 pandemicDawn E Sugarman, Alisa B Busch, R Kathryn McHugh, et al.
The American Journal on Addictions|October 18, 2013
Clinician beliefs and attitudes about buprenorphine/naloxone diversionZev Schuman-Olivier, Hilary Connery, Margaret L Griffin, et al.
Journal of Substance Use and Addiction Treatment|December 9, 2025
A clinical trial loses access to some of its experimental treatment conditions: What can be done?Sarah Meyers-Ohki, Matisyahu Shulman, Roger D Weiss, et al.
The American Journal of Drug and Alcohol Abuse|August 23, 2011
Ten take home lessons from the first 10 years of the CTN and 10 recommendations for the futureKathleen M Carroll, Samuel A Ball, Ron Jackson, et al.
The American Journal of Psychiatry|December 17, 2009
Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)Michael J Ostacher, Roy H Perlis, Andrew A Nierenberg, et al.
Archives of General Psychiatry|November 4, 2009
Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populationsPingxing Xie, Henry R Kranzler, James Poling, et al.
Journal of Substance Abuse Treatment|January 15, 2013
Gender differences in a clinical trial for prescription opioid dependenceR Kathryn McHugh, Elise E Devito, Dorian Dodd, et al.
JAMA Network Open|March 17, 2023
Association of Household Opioid Availability With Opioid OverdoseMichelle A Hendricks, Sanae El Ibrahimi, Grant A Ritter, et al.
Journal of Dual Diagnosis|April 1, 2026
Investigating the Effects of Buprenorphine Treatment on Depression Symptoms Among Adults with Opioid Use Disorder: A Scoping ReviewVictoria R Votaw, Rachel L Rosen, Andrew D Peckham, et al.
JAMA Network Open|August 20, 2025
Behavioral Therapy as an Adjunct to Buprenorphine Treatment for Opioid Use Disorder: A Secondary Analysis of 4 Randomized Clinical TrialsR Kathryn McHugh, Allen J Bailey, Brooke A McConaghy, et al.
Pageof 28

Showing results (201-210 of 271) with videos related to

Sort By:
Pageof 28
The American Journal on Addictions|August 18, 2021
Patients' perceptions of telehealth services for outpatient treatment of substance use disorders during the COVID-19 pandemicDawn E Sugarman, Alisa B Busch, R Kathryn McHugh, et al.
The American Journal on Addictions|October 18, 2013
Clinician beliefs and attitudes about buprenorphine/naloxone diversionZev Schuman-Olivier, Hilary Connery, Margaret L Griffin, et al.
Journal of Substance Use and Addiction Treatment|December 9, 2025
A clinical trial loses access to some of its experimental treatment conditions: What can be done?Sarah Meyers-Ohki, Matisyahu Shulman, Roger D Weiss, et al.
The American Journal of Drug and Alcohol Abuse|August 23, 2011
Ten take home lessons from the first 10 years of the CTN and 10 recommendations for the futureKathleen M Carroll, Samuel A Ball, Ron Jackson, et al.
The American Journal of Psychiatry|December 17, 2009
Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)Michael J Ostacher, Roy H Perlis, Andrew A Nierenberg, et al.
Archives of General Psychiatry|November 4, 2009
Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populationsPingxing Xie, Henry R Kranzler, James Poling, et al.
Journal of Substance Abuse Treatment|January 15, 2013
Gender differences in a clinical trial for prescription opioid dependenceR Kathryn McHugh, Elise E Devito, Dorian Dodd, et al.
JAMA Network Open|March 17, 2023
Association of Household Opioid Availability With Opioid OverdoseMichelle A Hendricks, Sanae El Ibrahimi, Grant A Ritter, et al.
Journal of Dual Diagnosis|April 1, 2026
Investigating the Effects of Buprenorphine Treatment on Depression Symptoms Among Adults with Opioid Use Disorder: A Scoping ReviewVictoria R Votaw, Rachel L Rosen, Andrew D Peckham, et al.
JAMA Network Open|August 20, 2025
Behavioral Therapy as an Adjunct to Buprenorphine Treatment for Opioid Use Disorder: A Secondary Analysis of 4 Randomized Clinical TrialsR Kathryn McHugh, Allen J Bailey, Brooke A McConaghy, et al.
Pageof 28